Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mass Spectrometry Software Integrated with Proteomics Data Analysis System

By LabMedica International staff writers
Posted on 14 Oct 2009
Geneva Bioinformatics, SA (GeneBio; Geneva, Switzerland) and Integromics S.L. More...
(Madrid, Spain) reported that GeneBio's Phenyx software platform for mass spectrometry (MS) data analysis has been successfully integrated into Integromics' latest proteomics data analysis and management tool--OmicsHub Proteomics. This integration gives Phenyx and OmicsHub Proteomics users the possibility of combining results from different search engines, thereby increasing the accuracy of the protein identification process.

OmicsHub Proteomics serve as an end-to-end proteomics data analysis and management system, from protein peak detection to generation of final reports. It has been developed in cooperation with ProteoRed, the Spanish National Proteomics Network (Madrid, Spain), ensuring in this way that the solution is close to the reality of a proteomics laboratory and that it helps to solve the most typical traffic jams of this field.

Developed in collaboration with the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland), Phenyx is GeneBio's software platform for the identification, quantization, and characterization of proteins and peptides from mass spectrometry data. The Phenyx platform is specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment via a customizable architecture and a novel user-friendly interface.

"One of the biggest advantages of OmicsHub Proteomics is that we can have integrated in one single platform all the steps of an MS experiment thus reducing time and data management complexity,” said Dr. Juan Pablo Albar, general coordinator of ProteoRed. "As our feedback contributed from the early stages of its creation, OmicsHub Proteomics solves typical problems we find on a daily basis and makes life easier when performing tasks such as multiple search engine support, pathways integration or report generation for external customers. On the other hand, we are glad to see that commercial companies also include in their software functionality which helps laboratories to easily meet proteomics standards such as PRIDE [PRoteomics IDEntifications] or MIAPE [Minimum Information About a Proteomics]. Since Phenyx is widely used within our network due to its unique capabilities for protein identification, OmicsHub enables our members to take a greater advantage of a central solution like Phenyx.”

"We are pleased with the integration of Phenyx within OmicsHub Proteomics as this should open up Phenyx to a host of new users,” said Nasri Nahas, CEO of GeneBio. "The OmicsHub Proteomics platform answers proteomics researchers' needs for proteomics data automation and data management/analysis; combined with the outstanding performance of Phenyx, we envision a winning platform that will immediately bring great value to users and at the same time instantly expand the potential Phenyx user base. We are excited about the future possibilities of this relationship.”

"With OmicsHub Proteomics, Integromics has stepped into the proteomics field, and we view proteomics as an area where Integromics can leverage its expertise in the life sciences industry and add value. OmicsHub Proteomics has been designed to provide a custom proteomics solution and the integration of Phenyx will provide our end users added flexibility in the protein analysis process,” said Prof. Jose Maria Carazo, CSO of Integromics.

Both Integromics S.L. and GeneBio presented their technology at HUPO 2009 in Toronto, Canada, on September 26-30, 2009.

Geneva Bioinformatics is a leading bioinformatics company providing the life science community with software that bridges the gap between information gathering and knowledge generation. The company focuses on mass spectrometry characterization of proteins and small molecules as well as proteome imaging, offering clients and partners a high degree of specialization essential to their research.

Integromics develops information technology (IT) systems for Life Sciences (genomics and proteomics) in two strategic areas: data management/integration and intelligent data analysis. The company has developed a network of collaborations and partnerships with leading industry and academic organizations to provide complete technologic solutions that enable scientists to make new discoveries from their research data. Integromics operates globally in Asia Pacific, Europe, and the United States.

Related Links:

Geneva Bioinformatics
Integromics
ProteoRed
Swiss Institute of Bioinformatics



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
ESR Analyzer
TEST1 2.0
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.